via Pharmaceutical Journal
Saliva could be used instead of blood to monitor diabetes in a method proposed in research involving the University of Strathclyde.
The test has been developed as an alternative to the current prevalent practice of monitoring blood glucose, which can be invasive, painful and costly.
Lab tests of the saliva process had an accuracy rate of 95.2%. The research shows promising results for monitoring diabetes, which affects an estimated 425 million people worldwide – around half of them undiagnosed.
The research has been published in the journal PLOS One. It also involved partners at the Federal University of Uberlandia in Minas Gerais, Brazil, the University of Vale do Paraíba in Sao Paolo, Brazil and the University of Saskatchewan in Canada.
Dr Matthew Baker, a Reader in Strathclyde’s Department of Pure and Applied Chemistry and lead researcher in the project, said: “Frequent monitoring of diabetes is essential for improved glucose control and to delay clinical complications related to the condition. Early screening is also paramount in reducing these complications worldwide.
“Blood analysis for screening, monitoring and diagnosing diabetes is widely practised but is quite invasive and painful. The constant need of piercing the fingers several times daily for most patients may lead to the development of finger calluses, as well as difficulty in obtaining blood samples; furthermore, not everyone would want to give blood and there are circumstances in which it could be dangerous.
“Saliva reflects several physiological functions of the body, such as emotional, hormonal, nutritional and metabolic, and so its biomarkers could be an alternative to blood for robust early detection and monitoring. It is easy to collect, non-invasive, convenient to store and requires less handling than blood during clinical procedures, while also being environmentally efficient. It also contains analytes with real-time monitoring value which can be used to check a person’s condition.”
Dr Robinson Sabino-Silva, an associate professor at Federal University of Uberlandia (UFU) and a partner in the research, said: “The present protocol used in the infrared platform is able to detect spectral biomarkers without reagents. The combination of a non-invasive salivary collection and a reagent-free analysis permit us to monitor diabetes with a sustainable platform classified as green technology.“
The lab tests used a scientific system known as Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy. This has been used in the diagnosis of several diseases, although its applications in the monitoring of diabetic treatment have begun to emerge only recently. Samples were assessed in three categories – diabetic, non-diabetic and insulin-treated diabetic – and two potential diagnostic biomarkers were identified.
The researchers are hopeful that the process they have developed could be used for both Type 1 and Type 2 diabetes, although further study will be required to confirm this.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Monitoring diabetes
- Medtronic: Managing Her Diabetes ‘Runner’s High’
High blood sugar, called hyperglycemia, occurs in people with diabetes when there is not enough insulin to regulate the amount of glucose in the blood.
- 224 Injured After Glitchy Diabetes App Drains Insulin Pump Batteries
At least 224 people have been injured after an iPhone app called t:connect drained the battery on its accompanying insulin pump, called t:slim X2, causing the pump to fail to deliver insulin. The FDA ...
- Continuous Glucose Monitoring Systems Market (CAGR) of 23.55%, Unlocking Consumer Minds How Focus Groups Enhance Qualitative Research
The report’s in-depth market assessment and examination of client and furnish chain dynamics features aid organizations in developing their sales, marketing, and merchandising strategies. Additionally ...
- Senseonics, Rimidi team up on diabetes monitoring solution
Senseonics (NYSE:SENS) stock rose 3% in post-market trading Thursday after the implantable glucose monitor developer said it is partnering with clinical management platform provider Rimidi on the ...
- Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
Senseonics, in collaboration with its commercial partner, Ascensia Diabetes Care, intends to make the Eversense CGM+RPM solution available to select population health-based systems beginning in the ...
Go deeper with Google Headlines on:
Monitoring diabetes
[google_news title=”” keyword=”monitoring diabetes” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Diabetes
- Breakthrough treatment offers hope for Type 1 diabetes patients
With Tzield offering newfound optimism for Type 1 diabetes patients, Holdt's story serves as a beacon of hope, illustrating the potential of medical advancements to enhance quality of life. Holdt said that this treatment is a breakthrough for him and countless others.
- Young People with Diabetes May Face Higher Alzheimer's Risk
A new study suggests that early-onset diabetes may increase the risk of Alzheimer’s disease. Controlling diabetes with lifestyle changes or medication may help lower dementia risk, experts say.
Go deeper with Google Headlines on:
Diabetes
[google_news title=”” keyword=”diabetes” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]